Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hcv Hepatitis'

Hcv Hepatitis published presentations and documents on DocSlides.

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

  • sophia2
  • 9 Slides

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

HA-REACT Joint Action WP4 Testing and Linkage to care

HA-REACT Joint Action WP4 Testing and Linkage to care

  • delilah
  • 10 Slides

Methods:. Trainings in two Focus Countries. (. La...

Ghazala Rubi B.Sc , M.Sc

Ghazala Rubi B.Sc , M.Sc

  • badra
  • 37 Slides

,. F.I.B.M.S;. MPhil. (. Mol.Bio. ). PhD (Human G...

SMV + DCV + SOF Open label

SMV + DCV + SOF Open label

  • summer
  • 6 Slides

≥ 18 years. Chronic HCV infection. Genotype 1 or...

Daclatasvir - Asunaprevir

Daclatasvir - Asunaprevir

  • queenie
  • 9 Slides

-. Beclabuvir in GT1 Patients without Cirrhosis. U...

Laboratory Diagnosis of Infectious Viral Diseases

Laboratory Diagnosis of Infectious Viral Diseases

  • LittleMissPerfect
  • 48 Slides

Prof. Ahmed S. Abdel-Moneim. College of Medicine-T...

Internal ControlExpiration DateAmplification Reagent PackCAUTION Hand

Internal ControlExpiration DateAmplification Reagent PackCAUTION Hand

  • carny
  • 16 Slides

is proportional to the log of the HCV RNA concentr...

Validation of Viral Load Assays

Validation of Viral Load Assays

  • elise
  • 25 Slides

for Diagnostics: New York State’s Experience M...

CORPORATE HEADQUARTERS

CORPORATE HEADQUARTERS

  • yvonne
  • 4 Slides

3043-02 904 Caribbean Drive Sunnyvale, CA 94089 US...

PreventionofviralhepatitisBandCreassessedKoenVanHerckMDPhDPostdocto

PreventionofviralhepatitisBandCreassessedKoenVanHerckMDPhDPostdocto

  • riley
  • 21 Slides

*Correspondingauthor.CentrefortheEvaluationofVacci...

Glecaprevir - Pibrentasvir

Glecaprevir - Pibrentasvir

  • isabella2
  • 8 Slides

in HCV GT 1 & Prior DAA Treatment. MAGELLAN-1 ...

TURQUOISE-I: SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASABUVIR, AND RIBAVIRIN IN PATIENTS CO-I

TURQUOISE-I: SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASABUVIR, AND RIBAVIRIN IN PATIENTS CO-I

  • eloise
  • 18 Slides

20. th. International AIDS Conference. • . Melb...

Elbasvir-Grazoprevir in

Elbasvir-Grazoprevir in

  • esther
  • 9 Slides

HCV . GT 1,4, or 6 in PWID* on Opiate Agonist Ther...

Boceprevir with PEG + RBV in Genotype 1

Boceprevir with PEG + RBV in Genotype 1

  • caroline
  • 7 Slides

SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...

Henry Masur , MD Bethesda, Maryland

Henry Masur , MD Bethesda, Maryland

  • rodriguez
  • 30 Slides

CROI Update 2016. FORMATTED: MM/DD/YY. From . H . ...

Breakout session Ryan White

Breakout session Ryan White

  • lydia
  • 26 Slides

Marion Peters. August 2020. ARS Question 1:. Which...

HIV…HBV…HCV Triple Elimination

HIV…HBV…HCV Triple Elimination

  • hazel
  • 30 Slides

What will it take to achieve?. HIV and Co-infectio...

1 Clarify Informed Consent of Transmittable Conditions

1 Clarify Informed Consent of Transmittable Conditions

  • callie
  • 19 Slides

Ad Hoc Disease Transmission Advisory Committee (DT...

Housing Choice Voucher (HCV)

Housing Choice Voucher (HCV)

  • susan2
  • 71 Slides

Homeownership Program. 2022. 1. Introduction. The ...

Performance evaluation of the Hologic

Performance evaluation of the Hologic

  • ariel
  • 8 Slides

Aptima. HCV Quant . Dx. assay for detection of H...

MEDICAL CENTER “MRCHEVELI”

MEDICAL CENTER “MRCHEVELI”

  • elina
  • 14 Slides

MEDICAL CENTER “MRCHEVELI”. Case Presentation:...

Methods Design Analysis of routine patient data and survey data

Methods Design Analysis of routine patient data and survey data

  • jones
  • 1 Slides

Study Population . A. ll . HIV-positive adults . s...

Marion G. Peters, MD John V. Carbone, MD, Endowed Chair

Marion G. Peters, MD John V. Carbone, MD, Endowed Chair

  • ashley
  • 8 Slides

Professor of Medicine. Chief of Hepatology Researc...

Simeprevir in HIV Coinfection,

Simeprevir in HIV Coinfection,

  • noah
  • 9 Slides

GT-1. C212 Trial. Phase . 3. Treatment. Naïve an...

FISSION Design Objective

FISSION Design Objective

  • travis
  • 6 Slides

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Listing General Transplant Purpose

Listing General Transplant Purpose

  • creed487
  • 27 Slides

Revised 2/18/19. 1. Purpose of Transplant. Our goa...

Liver Disease and HIV Infection

Liver Disease and HIV Infection

  • landyn185
  • 32 Slides

Marion G. Peters, MD. Professor . of Medicine. Nor...

GMJ Sero prevalence of HBV HCV HIV and syphilis among

GMJ Sero prevalence of HBV HCV HIV and syphilis among

  • kittie-lecroy
  • 5 Slides

Nirali Shah Dr JMShah Dr Preeti Jhaveri Dr Kazoom...

GlobalDistributionandPrevalenceofHepatitis

GlobalDistributionandPrevalenceofHepatitis

  • mitsue-stanley
  • 11 Slides

CVirusGenotypes JaneP.Messina, 1 IslaHumphreys, 2 ...

Distribution pattern of HCV genotypes & its association with

Distribution pattern of HCV genotypes & its association with

  • kittie-lecroy
  • 6 Slides

viral load Anita Chakravarti, Gaurav Dogra, Vikas...

Dry, Itchy Skin and Mild RashTake short, warm (not hot) baths or showe

Dry, Itchy Skin and Mild RashTake short, warm (not hot) baths or showe

  • natalia-silvester
  • 2 Slides

Tips to Lessen of HCV TherapyFrom the American Col...

State of the Art Therapy for HCV

State of the Art Therapy for HCV

  • liane-varnes
  • 56 Slides

Last Updated: February . 21, 2014. Robert G. Gish...

3 D (Paritaprevir

3 D (Paritaprevir

  • myesha-ticknor
  • 13 Slides

-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...

C-SCAPE

C-SCAPE

  • pasty-toler
  • 14 Slides

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

SIRIUS

SIRIUS

  • tawny-fly
  • 10 Slides

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

Treatment for 12 or 24 weeks with BI201335 combined with pe

Treatment for 12 or 24 weeks with BI201335 combined with pe

  • lindy-dunigan
  • 17 Slides

Results of the SILEN-C3 trial. SILEN-C3 trial . M...

Dore G. J

Dore G. J

  • pasty-toler
  • 10 Slides

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

DermatologicalsideeffectsofhepatitisCanditstreatment:Patientmanagement

DermatologicalsideeffectsofhepatitisCanditstreatment:Patientmanagement

  • karlyn-bohler
  • 100 Slides

JournalofHepatologyvol.56 Keywords:HCV;HepattitisC...

26/07/2013

26/07/2013

  • alida-meadow
  • 14 Slides

1. Le 29-01-2015. Les anticorps neutralisants ant...

Special session #10:

Special session #10:

  • alexa-scheidler
  • 34 Slides

GRADE: the past 15 and next … years. ...

Copyright © 2024 DocSlides. All Rights Reserved